Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis-Reference-Cited by-同舟云学术

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis

Published:2016-07-27 Issue:1 Volume:11 Page:84-91
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Shinzaki Shinichiro¹,Matsuoka Katsuyoshi²,Iijima Hideki¹,Mizuno Shinta³,Serada Satoshi⁴,Fujimoto Minoru⁴,Arai Norimitsu⁵,Koyama Noriyuki⁵,Morii Eiichi⁶,Watanabe Mamoru²,Hibi Toshifumi⁷,Kanai Takanori³,Takehara Tetsuo¹,Naka Tetsuji⁴

Affiliation:

1. Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan

2. Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan

3. Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

4. Laboratory of Immune Signal, National Institute of Biomedical Innovation, Health and Nutrition, Osaka, Japan

5. Department of Research and Development, EIDIA Co. Ltd, Tokyo, Japan

6. Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan

7. Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan

Funder

Japan Agency for Medical Research and Development

Eidia Co. Ltd

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/11/1/84/28798383/jjw132.pdf

Reference30 articles.

1. Mucosal healing in inflammatory bowel diseases: a systematic review;Neurath;Gut,2012

2. Clinical implications of mucosal healing for the management of IBD;Pineton de Chambrun;Nat Rev Gastroenterol Hepatol,2010

3. Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer;Toniatti;Mol Biol Med,1990

4. C-reactive protein as a marker for inflammatory bowel disease;Vermeire;Inflamm Bowel Dis,2004

5. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn’s disease;Jones;Clin Gastroenterol Hepatol,2008

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers;Biomedicines;2024-07-08

2. Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond;Diagnostics;2024-06-28

3. LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma;Scientific Reports;2024-06-19

4. Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis;Intestinal Research;2024-06-05

5. Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis;Journal of Clinical Medicine;2024-05-17